| 标题 |
IMV101, a novel CD19-targeted In Vivo CAR T therapy exhibits potent efficacy and tolerable safety profiles in preclinical models |
| 网址 | |
| DOI |
10.1182/blood-2025-5875
doi
|
| 其它 |
期刊:Blood 作者:Shuangshuang Zhang; Yantao Li; Xiaojiang Fan; Qiaoyong Yi; Yue Zhang; et al 出版日期:2025-11-03 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)